Bender Robert & Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-22,373
Closed -$4.11M 51
2021
Q2
$4.11M Sell
22,373
-233
-1% -$42.8K 1.17% 20
2021
Q1
$3.46M Sell
22,606
-255
-1% -$39K 1.11% 22
2020
Q4
$3.57M Buy
22,861
+445
+2% +$69.5K 1.14% 23
2020
Q3
$2.57M Sell
22,416
-387
-2% -$44.3K 0.92% 24
2020
Q2
$2.56M Sell
22,803
-1,278
-5% -$143K 1.01% 24
2020
Q1
$2.16M Sell
24,081
-2,610
-10% -$234K 1.15% 22
2019
Q4
$2.89M Sell
26,691
-614
-2% -$66.4K 1.3% 23
2019
Q3
$2.67M Sell
27,305
-190
-0.7% -$18.6K 1.34% 24
2019
Q2
$3.15M Sell
27,495
-4,168
-13% -$478K 1.5% 21
2019
Q1
$4.28M Sell
31,663
-737
-2% -$99.6K 2.1% 19
2018
Q4
$3.15M Sell
32,400
-213
-0.7% -$20.7K 1.82% 21
2018
Q3
$4.53M Sell
32,613
-151
-0.5% -$21K 2.06% 19
2018
Q2
$4.07M Buy
32,764
+105
+0.3% +$13K 2.13% 18
2018
Q1
$3.64M Sell
32,659
-214
-0.7% -$23.9K 2.02% 20
2017
Q4
$3.93M Buy
32,873
+430
+1% +$51.4K 2.18% 21
2017
Q3
$4.55M Sell
32,443
-17
-0.1% -$2.39K 2.62% 17
2017
Q2
$3.95M Buy
32,460
+451
+1% +$54.9K 2.42% 19
2017
Q1
$3.88M Sell
32,009
-1,340
-4% -$162K 2.5% 18
2016
Q4
$4.08M Sell
33,349
-634
-2% -$77.6K 2.89% 15
2016
Q3
$4.16M Sell
33,983
-215
-0.6% -$26.3K 2.75% 15
2016
Q2
$3.99M Sell
34,198
-511
-1% -$59.7K 2.82% 12
2016
Q1
$4.83M Sell
34,709
-1,045
-3% -$145K 3.27% 12
2015
Q4
$6.82M Sell
35,754
-335
-0.9% -$63.9K 4.37% 7
2015
Q3
$5.64M Sell
36,089
-820
-2% -$128K 3.82% 8
2015
Q2
$6.67M Buy
36,909
+191
+0.5% +$34.5K 3.96% 7
2015
Q1
$6.36M Buy
36,718
+126
+0.3% +$21.8K 3.71% 12
2014
Q4
$6.77M Sell
36,592
-53
-0.1% -$9.81K 4.43% 7
2014
Q3
$6.08M Sell
36,645
-303
-0.8% -$50.2K 4.23% 8
2014
Q2
$5.77M Sell
36,948
-290
-0.8% -$45.3K 4.08% 8
2014
Q1
$5.67K Sell
37,238
-847
-2% -$129 3.8% 10
2013
Q4
$2.06M Sell
38,085
-136
-0.4% -$7.36K 1.55% 24
2013
Q3
$4.44M Sell
38,221
-127
-0.3% -$14.8K 3.48% 10
2013
Q2
$3.54M Buy
+38,348
New +$3.54M 3.04% 12